112 Participants Needed

Heat Therapy + Cold Water Plunge for Depression

(CHILL'D Trial)

SC
Overseen ByStudy Coordinator
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Vail Health Behavioral Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This study will recruit 112 medically healthy adults (aged 18-65) currently experiencing depressive symptoms to be randomized to receive either a single Whole Body Hyperthermia (heat therapy) treatment or a Whole Body Hyperthermia treatment followed by a cold water plunge. Participants will complete a baseline assessment of their depressive symptoms as well as 1-week and 2-week post-treatment followup assessments.

Will I have to stop taking my current medications?

The trial requires that you stop taking any medication that may affect your body's ability to regulate temperature.

What data supports the effectiveness of the treatment Heat Therapy + Cold Water Plunge for Depression?

Research suggests that whole-body hyperthermia (WBH), a component of heat therapy, shows promise as a treatment for depression, with studies indicating it can improve mood and reduce depressive symptoms. Additionally, hyperthermic baths, another form of heat therapy, have been found to have antidepressant effects when added to usual depression care.12345

How does the Heat Therapy + Cold Water Plunge treatment for depression differ from other treatments?

This treatment combines whole-body hyperthermia (raising body temperature) and cold water plunges, which are non-drug approaches that may help improve mood by activating the body's stress response and increasing certain brain chemicals. Unlike traditional antidepressants, this method uses temperature changes to potentially relieve depressive symptoms without medication.12367

Research Team

BS

Barry Sandler, DO

Principal Investigator

Vail Health Behavioral Health

Eligibility Criteria

This trial is for medically healthy adults aged 18-65 who are currently experiencing symptoms of depression. Participants must be able to complete baseline assessments and follow-ups at 1 and 2 weeks after treatment.

Inclusion Criteria

Montgomery-Asberg Depression Rating Scale (MADRS) score ≥ 28 at screening
Able and willing to adhere to trial requirements, including attending all trial visits, preparatory and follow-up sessions, and completing all trial evaluations.
I have been diagnosed with major depression lasting more than 60 days.
See 1 more

Exclusion Criteria

Pregnancy, active lactation, or intention to become pregnant during the study period
Endorses current active suicidal ideation with a plan or made a suicide attempt in the prior 6 months.
I am taking medication that could affect my body's ability to regulate temperature.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either a single Whole Body Hyperthermia treatment or a Whole Body Hyperthermia treatment followed by a cold water plunge

1 day
1 visit (in-person)

Follow-up

Participants complete assessments of depressive symptoms at 1-week and 2-week post-treatment

2 weeks
2 visits (in-person)

Treatment Details

Interventions

  • Cold Water Plunge
  • Whole Body Hyperthermia
Trial OverviewThe study is testing the effects of heat therapy alone versus heat therapy followed by a cold water plunge on depressive symptoms. A total of 112 participants will be randomly assigned to one of these two treatments.
Participant Groups
2Treatment groups
Active Control
Group I: Whole Body HyperthermiaActive Control1 Intervention
Participants in the heat exposure alone group will receive a single heat session using the Clearlight Sauna Dome lasting up to 140 minutes.
Group II: Whole Body Hyperthermia + Cold Water PlungeActive Control2 Interventions
Participants in the heat exposure and cold plunge group will receive a single heat session using the Clearlight Sauna Dome lasting up to 140 minutes followed by a cold plunge session lasting up to 10 minutes.

Whole Body Hyperthermia is already approved in European Union, United States, Switzerland for the following indications:

🇪🇺
Approved in European Union as Whole Body Hyperthermia for:
  • Depression
  • Other conditions
🇺🇸
Approved in United States as Whole Body Hyperthermia for:
  • Major Depressive Disorder
🇨🇭
Approved in Switzerland as Whole Body Hyperthermia for:
  • Depression

Find a Clinic Near You

Who Is Running the Clinical Trial?

Vail Health Behavioral Health

Lead Sponsor

Trials
1
Recruited
110+

Steadman Philippon Research Institute

Collaborator

Trials
11
Recruited
700+

Findings from Research

A single session of whole-body hyperthermia (WBH) using a commercially available infrared sauna successfully raised participants' core body temperature to 101.3°F, which is associated with reduced depressive symptoms in previous studies.
Participants reported significant reductions in self-reported negative affect and depression symptoms from one week before to one week after the WBH session, suggesting that this non-pharmacologic treatment may be effective for major depressive disorder.
Feasibility and acceptability of a Whole-Body hyperthermia (WBH) protocol.Mason, AE., Fisher, SM., Chowdhary, A., et al.[2022]
Whole-body hyperthermia (WBH) has shown promising effects on mood and depression symptoms, with 19 out of 21 study endpoints demonstrating significant effect sizes (Cohen's d of 0.8 or greater) across 7 studies involving 148 participants.
WBH interventions, which included hot baths and infrared heating, were generally safe with low risk of adverse reactions, but the evidence is still insufficient for broad clinical recommendations, highlighting the need for further research.
The impact of whole-body hyperthermia interventions on mood and depression - are we ready for recommendations for clinical application?Hanusch, KU., Janssen, CW.[2019]
In a pilot study involving 45 outpatients with moderate depression, hyperthermic baths (HTB) showed a significant reduction in depression severity after 2 weeks, with a mean improvement of 4.3 points on the Hamilton Depression Rating Scale compared to a physical exercise program.
HTB was well-tolerated with no serious adverse events reported, making it a promising and accessible add-on treatment for depression, especially for individuals who may struggle with traditional exercise.
Effects and feasibility of hyperthermic baths in comparison to exercise as add-on treatment to usual care in depression: a randomised, controlled pilot study.Naumann, J., Kruza, I., Denkel, L., et al.[2021]

References

Feasibility and acceptability of a Whole-Body hyperthermia (WBH) protocol. [2022]
The impact of whole-body hyperthermia interventions on mood and depression - are we ready for recommendations for clinical application? [2019]
Effects and feasibility of hyperthermic baths in comparison to exercise as add-on treatment to usual care in depression: a randomised, controlled pilot study. [2021]
Effects of hyperthermic baths on depression, sleep and heart rate variability in patients with depressive disorder: a randomized clinical pilot trial. [2018]
Whole-Body Hyperthermia for the Treatment of Major Depressive Disorder: A Randomized Clinical Trial. [2017]
Adapted cold shower as a potential treatment for depression. [2013]
Community-Delivered Heated Hatha Yoga as a Treatment for Depressive Symptoms: An Uncontrolled Pilot Study. [2021]